Silva Blas Y, Diringer MN, Lo B, Masjuan J, et al. Phase 1b Study to Evaluate Safety, Tolerability, and Maximum Tolerated Dose of PF-05230907 for Intracerebral Hemorrhage. Stroke 2020 Dec 4:STROKEAHA120029789. doi: 10.1161/STROKEAHA.120.029789.
PMID: 33272131